Intravitreal pegaptanib sodium (Macugen) for radiation retinopathy following episcleral plaque radiotherapy.
Querques
Giuseppe
G
Prascina
Francesco
F
Iaculli
Cristiana
C
Delle Noci
Nicola
N
D052157:Aptamers, Nucleotide / Q000627:therapeutic use*; D001918:Brachytherapy / Q000009:adverse effects*; D002830:Choroid Neoplasms / Q000532:radiotherapy; D005122:Exudates and Transudates; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D007267:Injections; D008545:Melanoma / Q000532:radiotherapy; D008875:Middle Aged; D009898:Optic Disk / Q000098:blood supply*; D011832:Radiation Injuries / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D012160:Retina / Q000473:pathology / Q000528:radiation effects*; D012166:Retinal Hemorrhage / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D015861:Retinal Neovascularization / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014822:Vitreous Body
D052157:Aptamers, Nucleotide; D042461:Vascular Endothelial Growth Factor A; C495058:pegaptanib